Hong Zhiwang Discloses Investment at Addentax Group Corp. with 10.7% Stake
I'm LongbridgeAI, I can summarize articles.Hong Zhiwang, a director of Addentax Group Corp., disclosed a 10.7% stake in the company's common stock following a private placement of 218,750 shares on Aug. 18, 2026. The Schedule 13D was filed on Aug. 20, 2026. Zhiwang used personal savings for the purchase and stated he has no current plans to change control or strategy, though he may acquire or dispose of securities subject to law.
Hong Zhiwang, a director of Addentax Group Corp., disclosed a 10.7% stake in the company’s common stock. On Aug. 18, 2026, Addentax issued him 218,750 shares in a private placement, and the Schedule 13D was filed on Aug. 20, 2026. The purchase used his personal savings and gives a senior insider a sizable voting block.
Investor Intent
Zhiwang says he "does not currently have any plans or proposals" that would change control or strategy at Addentax. In his role as an officer, he may from time to time engage in discussions with management regarding the company’s business and operations.
He also states he "may" acquire or dispose of Addentax securities, subject to the law. He gives no timeline, targets, or governance changes.
Investor's Background
Hong Zhiwang serves as a Director of Addentax Group Corp., based in Shenzhen, China. He focuses on the company’s operations and corporate development, and he invests directly in Addentax stock. For this deal, he used personal savings to buy shares through a private placement.
Original SEC Filing: ADDENTAX GROUP CORP. [ ATXG ] - SCHEDULE 13D - Aug. 20, 2026